VivoSim Labs, INC.
VIVS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001497253
In the last 90 days, VivoSim Labs, INC. insiders filed 1 open-market purchase and 0 sales; 25 institutions reported holding it in 13F filings for Q2 2026, worth $109.7K in total; no superinvestor holds it.
Holders of 5% or more of VIVS
Holders whose latest Schedule 13D or 13G filing reports 5% or more of VivoSim Labs, INC., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of VivoSim Labs, INC. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
2 Schedule 13D and 13G filings on VivoSim Labs, INC., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| May 15, 20253:35 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 4.99%102.5K shares | −5.00 ppfrom 9.99%Below 5% | Mar 31, 2025 | SEC |
| Feb 14, 20255:15 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 9.99%1.70M shares | – | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell VivoSim Labs, INC. shares.
No Form 144 notices for VivoSim Labs, INC. are on file.